Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × apalutamide × Head & Neck × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 34 Head & Neck 1

Conditions

Salivary Gland Neoplasms 1

Interventions

pembrolizumab 144 Cisplatin 96 Cetuximab 61 Nivolumab 50 Carboplatin 44 Paclitaxel 41 Fluorouracil 38 Docetaxel 34 Gemcitabine 27 Radiotherapy 25 lenvatinib 15 Injections 15 atezolizumab 14 Capecitabine 14 durvalumab 13 cemiplimab 13 Cyclophosphamide 13 spartalizumab 12 Ipilimumab 12 fludarabine 9 avelumab 9 Pemetrexed 9 Gefitinib 9 epacadostat 8 budigalimab 8 Oxaliplatin 8 Drug Therapy 8 130-nm albumin-bound paclitaxel 8 tremelimumab 7 toripalimab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04325828 2026-02-13

YATAGARASU

Janssen Pharmaceutical K.K.

Phase 2 Active not recruiting

31 enrolled 15 charts

Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡